Device manufacturer, as written on reports
C R Bard: medical device reports filed with FDA
5,145 reports name it as the manufacturer of the device involved, 1992–2026.
- 5,145
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 166
- reports, 12 months to August 2026
- 271 in the 12 months before
- 40.4%
- classified as malfunction
- 62.3% across all reports
- 0.7%
- classified as death, as reported
- 0.9% across all reports
5,145 medical device reports received by FDA give C R Bard as the manufacturer of the device involved, 0% of the MAUDE database, from April 1992 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
166 reports arrived in the 12 months to August 2026, down 39% from 271 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (54.6%), malfunction (40.4%) and other (2.5%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Unknown Women's Health Product | Mesh, surgical, polymeric | 373 | 0 | 0% |
| Bard Tegress Urethral Bulking Agent | Agent, bulking, injectable for gastro-urology use | 220 | 0 | 0% |
| Bard | Port & catheter, implanted, subcutaneous, intravascular | 196 | 2 | 1.8% |
| Unknown Women's Health Mesh Product | Mesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed | 151 | 0 | 0% |
| Avaulta Plus Biosynthetic Support System | Mesh, surgical, polymeric | 115 | 0 | 0% |
| Align Urethral Support System | Mesh, surgical, polymeric | 67 | 0 | 0% |
| Pelvisoft Acellular Collagen Biomesh | Mesh, surgical | 58 | 0 | 0% |
| Align To Urethral Support System | Mesh, surgical, polymeric | 48 | 0 | 0% |
| SureStep Foley Tray System Bardex IC Complete Care | Catheter, urological (antimicrobial) and accessories | 40 | 7 | 0% |
| Foley Catheter | Catheter, urological | 39 | 2 | 0.8% |
| Bardex Lubri-Sil All-Silicone Temp Sensing Foley Catheter | Catheter, retention type, balloon | 33 | 62 | 0% |
| Bard DigniShield Stool Management System | Tubes, gastrointestinal (and accessories) | 30 | 94 | 0.7% |
| Surestep | Glucose oxidase, glucose | 30 | 0 | 0.1% |
| Bardex Lubri-Sil All-Silicone Foley Catheter | Catheter, retention type, balloon | 25 | 294 | 0.1% |
| Pelvilace Biourethral Support System | Mesh, surgical, polymeric | 22 | 0 | 0.3% |
| Avaulta Plus Biosynthetic Support System - Anterior | Mesh, surgical, polymeric | 19 | 0 | 0% |
| Avaulta Plus Biosynthetic Support System - Posterior | Mesh, surgical, polymeric | 17 | 0 | 0% |
| Pelvilace To Biourethral Support System | Mesh, surgical, polymeric | 17 | 0 | 0% |
| Bardex All-Silicone Foley Catheter | Catheter, retention type, balloon | 15 | 196 | 0% |
| Ajust Adjustable Single Incision Sling | Mesh, surgical, polymeric | 14 | 0 | 0% |
| Channel Drain | Catheter, irrigation | 14 | 66 | 0% |
| PureWick Female External Catheter | Collector, urine, powered, non indwelling catheter | 12 | 114 | 0.6% |
| Bardex Lubricath Foley Catheter | Catheter, coude | 11 | 653 | 0% |
| Closed Wound Suction | Apparatus, suction, single patient use, portable, nonpowered | 10 | 80 | 0% |
| Bardex Lubri-Sil I.C. All-Silicone Foley Catheter | Catheter, urological (antimicrobial) and accessories | 8 | 620 | 0% |
| Pelvicol Acellular Collagen Matrix | Mesh, surgical, polymeric | 7 | 0 | 0% |
| Align R Urethral Support System | Mesh, surgical, polymeric | 6 | 0 | 0% |
| Align S Urethral Support System | Mesh, surgical, polymeric | 4 | 0 | 0% |
| Bard Touchless Plus Unisex Pre-Lubricated Vinyl Urethral Catheter Kit | Tray, catheterization, sterile urethral, with or without catheter (kit) | 4 | 22 | 0% |
| Bardex I.C. Foley Catheter | Catheter, urological (antimicrobial) and accessories | 4 | 562 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| FTL | Mesh, surgical, polymeric | 1,279 | 24.9% |
| KOD | Catheter, urological | 576 | 11.2% |
| EZL | Catheter, retention type, balloon | 489 | 9.5% |
| GCY | Apparatus, suction, single patient use, portable, nonpowered | 266 | 5.2% |
| MJC | Catheter, urological (antimicrobial) and accessories | 262 | 5.1% |
| LNM | Agent, bulking, injectable for gastro-urology use | 233 | 4.5% |
| EZC | Catheter, coude | 166 | 3.2% |
| LJT | Port & catheter, implanted, subcutaneous, intravascular | 159 | 3.1% |
| OTP | Mesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed | 129 | 2.5% |
| LJS | Catheter, intravascular, therapeutic, long-term greater than 30 days | 122 | 2.4% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about C R Bard reports
How many FDA device reports name C R Bard as manufacturer?
5,145 reports through August 2026, 166 of them in the latest 12 months.
Which of its brands appear most often?
Unknown Women's Health Product (373), Bard Tegress Urethral Bulking Agent (220), Bard (196), Unknown Women's Health Mesh Product (151) and Avaulta Plus Biosynthetic Support System (115).
Which device types does it report on?
mesh, surgical, polymeric (24.9%), catheter, urological (11.2%), catheter, retention type, balloon (9.5%) and apparatus, suction, single patient use, portable, nonpowered (5.2%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.